Prevention of bronchopulmonary dysplasia: a cross-sectional survey of clinical practices in Canada
- PMID: 35461331
- DOI: 10.1038/s41372-022-01395-5
Prevention of bronchopulmonary dysplasia: a cross-sectional survey of clinical practices in Canada
References
-
- Lapcharoensap W, Lee HC, Nyberg A, Dukhovny D. Health care and societal costs of bronchopulmonary dysplasia. Neoreviews. 2018;19:e211–23. - DOI
-
- Shah PS, Dunn M, Aziz K, Shah V, Deshpandey A, Mukerji A, et al. Sustained quality improvement in outcomes of preterm neonates with a gestational age less than 29 weeks: results from the Evidence-based Practice for Improving Quality Phase 3 (1). Can J Physiol Pharm. 2019;97:213–21. - DOI
-
- Poets CF, Lorenz L. Prevention of bronchopulmonary dysplasia in extremely low gestational age neonates: current evidence. Arch Dis Child Fetal Neonatal Ed. 2018;103:F285–f91. - DOI
-
- Onland W, Debray TP, Laughon MM, Miedema M, Cools F, Askie LM, et al. Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study. BMC Pediatr. 2013;13:207. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources